Monoclonal anti-CXCL13 antibodies

Details for Australian Patent Application No. 2008217581 (hide)

Owner AstraZeneca AB Medimmune Limited

Inventors Barker, Wendy; Keyes, Feenagh Anne

Agent Davies Collison Cave

Pub. Number AU-A-2008217581

PCT Pub. Number WO2008/102123

Priority 60/890,888 21.02.07 US; 60/908,041 26.03.07 US

Filing date 20 February 2008

Wipo publication date 28 August 2008

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/102123 Priority application(s): WO2008/102123

5 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008217582-Depilatory composition

2008217579-Formation of lipid bilayers